Fermenta Biotech (BOM:506414) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Fermenta Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Fermenta Biotech's Free Cash Flow for the three months ended in Sep. 2024 was ₹0 Mil. Fermenta Biotech's Revenue for the three months ended in Sep. 2024 was ₹950 Mil. Therefore, Fermenta Biotech's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Fermenta Biotech's current FCF Yield % is 7.45%.

The historical rank and industry rank for Fermenta Biotech's FCF Margin % or its related term are showing as below:

BOM:506414' s FCF Margin % Range Over the Past 10 Years
Min: -16.79 Med: 1.78 Max: 25.83
Current: 23.45

During the past 13 years, the highest FCF Margin % of Fermenta Biotech was 25.83%. The lowest was -16.79%. And the median was 1.78%.

BOM:506414's FCF Margin % is ranked better than
92.96% of 994 companies
in the Drug Manufacturers industry
Industry Median: 0.9 vs BOM:506414: 23.45

Fermenta Biotech FCF Margin % Historical Data

The historical data trend for Fermenta Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fermenta Biotech FCF Margin % Chart

Fermenta Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

-11.62

1.97

1.59

21.66

25.83

Fermenta Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Fermenta Biotech's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fermenta Biotech's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's FCF Margin % falls into.

Fermenta Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Fermenta Biotech's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	861.388	/	3334.625
	=	25.83 %

Fermenta Biotech's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	0	/	950.279
	=	0.00 %

Fermenta Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Fermenta Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fermenta Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fermenta Biotech Ltd (BOM:506414) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610

Website

https://www.fermentabiotech.com

Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.

Fermenta Biotech Headlines

No Headlines